Literature DB >> 7215085

Elevated leg systolic pressures and arterial calcification in diabetic occlusive vascular disease.

M A Emanuele, B J Buchanan, C Abraira.   

Abstract

Systolic occlusion leg and brachial pressures were determined using a Doppler ultrasonic method in 24 diabetic subjects with either past or evolving gangrene due to arterial occlusive disease of the lower extremities. The leg-brachial ratios were correlated with x-ray determined leg vascular calcification. Ratios above 1.10 were invariably associated with heavy continuous calcification of the tibial vessels; lesser degrees of arterial calcification had normal or depressed leg-brachial ratios. Medial calcification might be causally related to the abnormally elevated leg systolic pressures not infrequently noted in diabetic patients. Based on the observed occurrence of reamputation in association with normal or elevated leg-brachial ratios, it appears that a Doppler pressure index above 0.90 is not a reliable indicator of adequate blood flow in severe diabetic occlusive arterial disease.

Entities:  

Mesh:

Year:  1981        PMID: 7215085     DOI: 10.2337/diacare.4.2.289

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  16 in total

1.  Critical analysis and limitations of resting ankle-brachial index in the diagnosis of symptomatic peripheral arterial disease patients and the role of diabetes mellitus and chronic kidney disease.

Authors:  Ali F AbuRahma; Elliot Adams; Joseph AbuRahma; Luis A Mata; L Scott Dean; Cristyn Caron; Jennifer Sloan
Journal:  J Vasc Surg       Date:  2019-08-27       Impact factor: 4.268

2.  An optimistic message for foot problems in diabetes.

Authors:  A Veves; A J Boulton
Journal:  West J Med       Date:  1993-01

3.  Venous distension in the diabetic neuropathic foot (physical sign of arteriovenous shunting).

Authors:  J D Ward; A J Boulton; J M Simms; D A Sandler; G Knight
Journal:  J R Soc Med       Date:  1983-12       Impact factor: 5.344

4.  Toe-brachial index as a predictor of cardiovascular disease and all-cause mortality in people with type 2 diabetes and microalbuminuria.

Authors:  Emilie H Zobel; Bernt Johan von Scholten; Henrik Reinhard; Frederik Persson; Tine W Hansen; Hans-Henrik Parving; Peter K Jacobsen; Peter Rossing
Journal:  Diabetologia       Date:  2017-07-05       Impact factor: 10.122

5.  QT interval abnormalities are often present at diagnosis in diabetes and are better predictors of cardiac death than ankle brachial pressure index and autonomic function tests.

Authors:  B S Rana; P O Lim; A A O Naas; S A Ogston; R W Newton; R T Jung; A D Morris; A D Struthers
Journal:  Heart       Date:  2005-01       Impact factor: 5.994

Review 6.  The diabetic leg.

Authors:  J D Ward
Journal:  Diabetologia       Date:  1982-03       Impact factor: 10.122

7.  Lower limb arterial incompressibility and obstruction in rheumatoid arthritis.

Authors:  I del Rincón; R W Haas; S Pogosian; A Escalante
Journal:  Ann Rheum Dis       Date:  2004-07-22       Impact factor: 19.103

8.  Peripheral arterial disease is associated with higher rates of hip bone loss and increased fracture risk in older men.

Authors:  Tracie C Collins; Susan K Ewing; Susan J Diem; Brent C Taylor; Eric S Orwoll; Steven R Cummings; Elsa S Strotmeyer; Kristine E Ensrud
Journal:  Circulation       Date:  2009-04-20       Impact factor: 29.690

9.  Role of comorbidities as limiting factors to the effect of hyperbaric oxygen in diabetic foot patients: a retrospective analysis.

Authors:  Esra A Akgül; Jale Karakaya; Salih Aydın
Journal:  Diabetes Ther       Date:  2014-10-02       Impact factor: 2.945

10.  Profound influence of different methods for determination of the ankle brachial index on the prevalence estimate of peripheral arterial disease.

Authors:  Stefan F Lange; Hans-Joachim Trampisch; David Pittrow; Harald Darius; Matthias Mahn; Jens R Allenberg; Gerhart Tepohl; Roman L Haberl; Curt Diehm
Journal:  BMC Public Health       Date:  2007       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.